- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03540602
Polyphenol Rich Supplementation on Markers of Recovery From Intense Resistance Exercise (PRSRE)
May 16, 2018 updated by: Jacksonville University
Strength training is commonly used as an intervention to increase muscle mass, thus improving a person's ability to undertake activities of daily living, or enhance athletic performance.
The strength training regimen itself, while ultimately having beneficial effects, causes muscle fibers to be damaged, which the body has to recover from.
As the body recovers, it rebuilds the muscle tissue and after multiple consecutive bouts of strength training, the muscle eventually becomes larger and stronger.
Thus, it is the recovery from strength training exercise that ultimately determines how well the body adapts.
Where inadequate recovery could eventually lead to overtraining and/or injury, optimizing the recovery process from strength training could maximize strength training adaptations.
This concept of optimizing recovery has led to development of many supplements, including antioxidants, which may reduce the damage associated with strength training activities and therefore enhance positive adaptations.
The purpose of this study is to assess the ability of a polyphenol rich supplementation to aid the recovery process from a demanding bout of resistance exercise
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Jacksonville, Florida, United States, 32211
- Recruiting
- Jacksonville University
-
Contact:
- Heather Hausenblaus, PhD
- Phone Number: 410-256-7975
- Email: hhausen@ju.edu
-
Contact:
- David Hooper, PhD
- Phone Number: 904-256-7985
- Email: dhooper4@ju.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 45 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- 6 months of resistance training experience with barbel back squat exercise
Exclusion Criteria:
- Not currently taking any antioxidant supplements, not currently using any hormone replacement therapy or anabolic androgenic steroids.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
PLACEBO_COMPARATOR: Placebo
Rice flour capsule
|
Rice flour
|
|
ACTIVE_COMPARATOR: Polyphenol Rich Supplement
NordicCherry Tart Cherry Extract Powder 500 mg in capsule form
|
NordicCherry Tart Cherry Extract Powder 500 mg from Specnova, inc
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of Oxidative Stress
Time Frame: 7 weeks
|
Blood analyses will be used, 8 mL of blood will be taken from the participant six times per condition.
The blood will be centrifuged to separate the serum/ plasma and analyzed by enzyme- linked immunosorbent assay (ELISA) for c- reactive protein and creatine kinase, and oxidative damage
|
7 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle soreness
Time Frame: 7 weeks
|
Subjects will mark a line on a 10cm scale that corresponds to the amount of muscular soreness they currently perceive
|
7 weeks
|
|
Vertical Jump Performance
Time Frame: 7 weeks
|
Subjects will be instructed to stand on a NeuroCom Balance Manager forceplate with hands on hips.
Subjects will then be instructed to perform 3 consecutive vertical jumps, as high as possible with minimal time between jumps.
The jumps will later be assessed for power production.
|
7 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Heather Hausenblaus, Jacksonville University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Reid MB. Invited Review: redox modulation of skeletal muscle contraction: what we know and what we don't. J Appl Physiol (1985). 2001 Feb;90(2):724-31. doi: 10.1152/jappl.2001.90.2.724.
- Alessio HM, Goldfarb AH, Cutler RG. MDA content increases in fast- and slow-twitch skeletal muscle with intensity of exercise in a rat. Am J Physiol. 1988 Dec;255(6 Pt 1):C874-7. doi: 10.1152/ajpcell.1988.255.6.C874.
- Blair SN, Cheng Y, Holder JS. Is physical activity or physical fitness more important in defining health benefits? Med Sci Sports Exerc. 2001 Jun;33(6 Suppl):S379-99; discussion S419-20. doi: 10.1097/00005768-200106001-00007.
- Powers SK, Jackson MJ. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev. 2008 Oct;88(4):1243-76. doi: 10.1152/physrev.00031.2007.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 1, 2018
Primary Completion (ANTICIPATED)
August 1, 2018
Study Completion (ANTICIPATED)
August 1, 2018
Study Registration Dates
First Submitted
February 26, 2018
First Submitted That Met QC Criteria
May 16, 2018
First Posted (ACTUAL)
May 30, 2018
Study Record Updates
Last Update Posted (ACTUAL)
May 30, 2018
Last Update Submitted That Met QC Criteria
May 16, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Polyphenol Supplementation
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle Soreness
-
Gazi UniversityCompletedDelayed Onset Muscle Soreness (DOMS)Turkey (Türkiye)
-
Applied Science & Performance InstituteNot yet recruitingMuscle Damage | Physical Performance | Muscle Recovery | Perceived Recovery | Strength Recovery | Perceived Muscle SorenessUnited States
-
University of MinnesotaRecruitingExercise Induced Muscle Damage | Delayed Onset Muscle Soreness (DOMS)United States
-
Ebru Aloğlu ÇiftçiThe Scientific and Technological Research Council of TurkeyCompletedHealthy | Delayed Onset Muscle Soreness (DOMS)Turkey (Türkiye)
-
University of Sistan and BaluchestanCompletedAthletic Injuries | Muscle Recovery | Exercise-induced Muscle Damage | Delayed-Onset Muscle Soreness (DOMS)Iran
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedDelayed-onset Muscle SorenessTaiwan
-
NewChapter, Inc.Procter and GambleCompletedDelayed Onset Muscle SorenessUnited States
-
Lotus Clinical Research, LLCNovartis PharmaceuticalsCompletedPain | Delayed Onset Muscle SorenessUnited States
-
Prof. Dr. med. Frank Christoph MoorenUniversity of Giessen; Biologische Heilmittel Heel GmbHCompletedExercise-induced Muscle SorenessGermany
-
Canopy Growth CorporationCompletedDelayed Onset Muscle Soreness (DOMS)United States
Clinical Trials on Placebo Oral Capsule [CEBOCAP]
-
Auburn UniversityCompleted
-
Sao Thai Duong Joint Stock CompanyBig Leap Clinical Research Joint Stock CompanyCompleted
-
Aelis FarmaNational Institute on Drug Abuse (NIDA)CompletedHealthy VolunteersUnited States
-
Brigham and Women's HospitalCompleted
-
Brigham and Women's HospitalEnrolling by invitation
-
EicOsis Human Health Inc.National Institute of Neurological Disorders and Stroke (NINDS)CompletedHealthy AdultsUnited States
-
Brigham and Women's HospitalCompleted
-
Georgetown UniversityNational Institutes of Health (NIH)CompletedDementia With Lewy BodiesUnited States
-
Alkermes, Inc.Terminated
-
InFlectis BioScienceAssistance Publique Hopitaux De Marseille; Qualissima; Eurofins Optimed; Stragen...Completed